Further founding clones encompassed TP53 and DDX41 mutations that did not give rise to further subclones, on the one hand providing evidence that these mutations define distinct entities, on the other hand indicating that these leukemia-initiating events are dependent on less transformative events. Here, TP53 is linked to leukemia.